These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 11552226)

  • 61. Evidence-based use of neoadjuvant taxane in operable and inoperable breast cancer.
    Estévez LG; Gradishar WJ
    Clin Cancer Res; 2004 May; 10(10):3249-61. PubMed ID: 15161677
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Primary chemotherapy with docetaxel for the management of breast cancer.
    Valero V
    Oncology (Williston Park); 2002 Jun; 16(6 Suppl 6):35-43. PubMed ID: 12108896
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Docetaxel-anthracycline combinations in metastatic breast cancer.
    Nabholtz JM
    Breast Cancer Res Treat; 2003; 79 Suppl 1():S3-9. PubMed ID: 12868800
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Single-agent treatment with pegylated liposomal doxorubicin for metastatic breast cancer.
    O'Brien ME
    Anticancer Drugs; 2008 Jan; 19(1):1-7. PubMed ID: 18043124
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Expanding options in breast cancer.
    Crown JP
    Anticancer Drugs; 1999 Nov; 10 Suppl 1():S19-24. PubMed ID: 10630364
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The international experience with docetaxel in the treatment of breast cancer.
    Ravdin PM
    Oncology (Williston Park); 1997 Mar; 11(3 Suppl 2):38-42. PubMed ID: 9110341
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Adjuvant use of taxanes for patients with breast cancer: we see the tip of the iceberg.
    Hudis C
    Clin Breast Cancer; 2002 Dec; 3(5):326-32. PubMed ID: 12533262
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Experimental chronotherapy of mouse mammary adenocarcinoma MA13/C with docetaxel and doxorubicin as single agents and in combination.
    Granda TG; Filipski E; D'Attino RM; Vrignaud P; Anjo A; Bissery MC; Lévi F
    Cancer Res; 2001 Mar; 61(5):1996-2001. PubMed ID: 11280758
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Primary systemic therapy (PST) of locally advanced breast cancer using Doxorubicin/Docetaxel combination.
    Dank M; Zergenyi E; Domotori ZS; Lahm E; Kulka J
    Anticancer Res; 2003; 23(3C):2879-80. PubMed ID: 12926127
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The role of taxanes in the adjuvant treatment of early stage breast cancer.
    Piccart M
    Breast Cancer Res Treat; 2003; 79 Suppl 1():S25-34. PubMed ID: 12868803
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Doxorubicin/paclitaxel combination does not expose breast cancer patients to excessive cardiac risk.
    Oncology (Williston Park); 2001 Jul; 15(7):830. PubMed ID: 11499684
    [No Abstract]   [Full Text] [Related]  

  • 72. Taxanes in the treatment of early breast cancer.
    Ring AE; Ellis PA
    Cancer Treat Rev; 2005 Dec; 31(8):618-27. PubMed ID: 16266787
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Weekly taxanes in metastatic breast cancer (review).
    Zimatore M; Danova M; Vassallo E; Porta C; Macaluso MC; Schittone L; Riccardi A; Palmeri S
    Oncol Rep; 2002; 9(5):1047-52. PubMed ID: 12168071
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The European experience with docetaxel in the treatment of early-stage breast cancer.
    Di Leo A
    Clin Breast Cancer; 2002 Oct; 3 Suppl 2():S59-62. PubMed ID: 12435289
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Sequential dose-dense adjuvant therapy with doxorubicin, paclitaxel, and cyclophosphamide.
    Hudis C
    Oncology (Williston Park); 1997 Apr; 11(4 Suppl 3):15-8. PubMed ID: 9144685
    [TBL] [Abstract][Full Text] [Related]  

  • 76. New developments in chemotherapy of advanced breast cancer.
    Lebwohl DE; Canetta R
    Ann Oncol; 1999; 10 Suppl 6():139-46. PubMed ID: 10676565
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The efficacy of chemotherapy with docetaxel and paclitaxel in anthracycline-resistant breast cancer (Review).
    Pivot X; Asmar L; Hortobagyi GN
    Int J Oncol; 1999 Aug; 15(2):381-6. PubMed ID: 10402251
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Taxane/anthracycline combinations: setting a new standard in breast cancer?
    Nabholtz JM; Riva A
    Oncologist; 2001; 6 Suppl 3():5-12. PubMed ID: 11346678
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Docetaxel (Taxotere) in combination with trastuzumab (Herceptin)].
    Ficorella C
    Tumori; 2001; 87(1 Suppl 2):S10-8. PubMed ID: 11357872
    [No Abstract]   [Full Text] [Related]  

  • 80. Combination of docetaxel and doxorubicin as first-line chemotherapy in metastatic breast cancer.
    Baltali E; Ozişik Y; Güler N; Firat D; Altundağ K
    Tumori; 2001; 87(1):18-9. PubMed ID: 11669551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.